Latest California Healthline Stories
Confianza, miedo y solidaridad marcarán el éxito de una vacuna contra COVID
Cuando una vacuna contra el coronavirus esté disponible, ¿la recibirán con una gran ovación, como la vacuna contra la polio, o con cierto letargo, como la vacuna contra el sarampión?
Test Sites Quickly Attract Thousands for COVID-19 Vaccine Study
People have flooded U.S. testing sites with requests to participate in the pivotal, late-stage clinical trials of the first two COVID-19 vaccine candidates.
America’s Obesity Epidemic Threatens Effectiveness of Any COVID Vaccine
Vaccines engineered to protect the public from influenza, hepatitis B, tetanus and rabies are less effective for obese people, leaving them more vulnerable to serious illness. As scientists race to develop a COVID-19 vaccine, experts say obesity could prove an impediment — a sobering prospect for a nation in which nearly half of all adults are obese.
Fauci Unfazed as Scientists Rely on Unproven Methods to Create COVID Vaccines
Teams are starting to test vaccines using messenger RNA or chimpanzee cold viruses to inoculate humans. Will their benefits last?
KHN’s ‘What The Health?’: Republicans in COVID Disarray
President Donald Trump’s sobering view of COVID-19 didn’t last long – this week, he was back to pushing hydroxychloroquine, a drug that has been shown not to work in treating the virus. Meanwhile, Republicans on Capitol Hill are still scrambling to agree among themselves and with the White House on the next coronavirus relief bill, as both a moratorium on evictions and extra unemployment payments expire. And the debate over drug prices, which was going to be one of the biggest health issues of this election year, makes a brief appearance. Alice Miranda Ollstein of Politico, Mary Ellen McIntire of CQ Roll Call and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Markian Hawryluk, who wrote the latest KHN-NPR “Bill of the Month” story about a surprise bill from a surprise surgical assistant.
Public Health Experts Fear a Hasty FDA Signoff on Vaccine
The FDA must approve any coronavirus vaccine before it’s widely distributed, but political pressure could cloud the decision.
A Coronavirus Vaccine: Where Does It Stand?
Under ordinary circumstances, these phases of vaccine development can take years to complete. But now, during the age of coronavirus, the timeline is being shortened. Here’s an inventory of where things stand.
Shingles Vaccination Rate Soars But Leaves Many Behind
A federal study finds 35% of people 60 and older were vaccinated for shingles by 2018, up from 7% in 2008, but low-income people and those who are Black or Hispanic are far less likely to get vaccinated.
La tasa de vacunación contra la culebrilla aumenta, pero muchos quedan atrás
Un nuevo informe de los Centros para el Control y Prevención de Enfermedades (CDC) revela que el porcentaje de vacunación es mucho más bajo entre las minorías.
Analysis: How A COVID-19 Vaccine Could Cost Americans Dearly
The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.